Future studies specifically investigating infection kinetics, viral-particle release, and the resulting antiviral response including the production of IL-6 and Type I/III interferons should facilitate definitive assessment of whether prior exposure to flagellin induces either a protective or damaging effect after SARS-CoV-2 infection of CF cells. Here, SGCG is linked to infection.